In this issue:
- 25-year trends in cancer incidence and mortality among adults aged 35-69 years
- Latest NCCN Guidelines in Kidney Cancer
- Characteristics and outcomes of lung cancer patients presenting through the ED
- Use of chemotherapy internationally in patients with solid tumours
- Nivolumab in patients with genetic alterations in DNA damage repair
- Use of radiotherapy internationally in patients with solid tumours
- Therapy resistance in prostate cancer
- Post-treatment supportive care in New Zealand
- Latest updates on Pharmac funding for cancer drugs
Please login below to download this issue (PDF)